Skip to content

The effect of Gh on pregnancy of PCO patients candidate for IVF

The effect of Gh on pregnancy outcome of PCO patients candidate for IVF

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20091012002576N31
Enrollment
100
Registered
2023-09-02
Start date
2023-09-23
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility. Female infertility of other origin

Interventions

Intervention 1: Intervention group:At second day of cycle Gh 10 unit subcutaneous daily will be injected plus rFSH till trigger day. Intervention 2: Control group: At second day of cycle rFSH will be

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: PCO patients candidate for IVF Susptible to ovarian hyperstimulation

Exclusion criteria

Exclusion criteria: Pathologic lesion in endometrial cavitypathologic User of corticosteroids or glucose control agents Liver disease Severe male infertility

Design outcomes

Primary

MeasureTime frame
Number of Oocytes MII. Timepoint: At OPU day. Method of measurement: Embryologist report.;Oocyte numbers. Timepoint: At OPU day. Method of measurement: Embryologist report.;Ovarian hyperstimulation syndrome. Timepoint: First week after OPU. Method of measurement: History & ultrasonography.

Secondary

MeasureTime frame
Chemical pregnancy. Timepoint: Two weeks after embryo transfer. Method of measurement: Bhcg test.;Clinical pregnancy. Timepoint: Four weeks after embryo transfer. Method of measurement: Four weeks after embryo transfer.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Davari Tanha

Tehran University of Medical Sciences

Fatedavtanha@gmail.com+98 21 8880 0115

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026